In the Breast Cancer Linkage Consortium cohort of 173 breast and/or ovarian cancer families, a RR of 4.7 (95%CI 3.5–6.2) was reported for prostate cancer among BRCA2 protein-truncating mutation carriers (BCLC, 1999). Here, BRCA2 is linked to prostate cancer.